The Research Impasse: Hindering Medical Advancement The current legal classification of certain substances, particularly cannabis and a range of psychedelics, presents a significant barrier to robust medical research and, consequently, patient access to potentially life-changing treatments. Under federal law in the United States, cannabis remains a Schedule I controlled substance, alongside heroin and LSD, implying […]